Literature DB >> 23254359

DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells.

Ken-Ichi Yamamoto1, Hitoshi Murata, Endy Widya Putranto, Ken Kataoka, Akira Motoyama, Toshihiko Hibino, Yusuke Inoue, Masakiyo Sakaguchi, Nam-Ho Huh.   

Abstract

Cellular migration is a fundamental process linked to cancer metastasis. Growing evidence indicates that the receptor for advanced glycation end products (RAGE) plays a pivotal role in this process. With regard to downstream signal transducers of RAGE, diaphanous-1 and activated small guanine nucleotide triphosphatases, Rac1 and Cdc42, have been identified. To obtain precise insight into the direct downstream signaling mechanism of RAGE, we screened for proteins interacting with the cytoplasmic domain of RAGE employing an immunoprecipitation-liquid chromatography coupled with an electrospray tandem mass spectrometry system. In the present study, we found that the cytoplasmic domain of RAGE interacted with an atypical DOCK180-related guanine nucleotide exchange factor, dedicator of cytokinesis protein 7 (DOCK7). DOCK7 bound to the RAGE cytoplasmic domain and transduced a signal to Cdc42, resulting in the formation of abundant highly branched filopodia-like protrusions, dendritic pseudopodia. Blocking of the function of DOCK7 greatly abrogated the formation of dendritic pseudopodia and suppressed cellular migration. These results indicate that DOCK7 functions as an essential and downstream regulator of RAGE-mediated cellular migration through the formation of dendritic pseudopodia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23254359     DOI: 10.3892/or.2012.2191

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Quantitative phosphoproteomic analysis of IL-33-mediated signaling.

Authors:  Sneha M Pinto; Raja Sekhar Nirujogi; Pamela Leal Rojas; Arun H Patil; Srikanth S Manda; Yashwanth Subbannayya; Juan Carlos Roa; Aditi Chatterjee; T S Keshava Prasad; Akhilesh Pandey
Journal:  Proteomics       Date:  2015-01       Impact factor: 3.984

2.  Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.

Authors:  Mikhail G Kolonin; Anna Sergeeva; Daniela I Staquicini; Tracey L Smith; Christy A Tarleton; Jeffrey J Molldrem; Richard L Sidman; Serena Marchiò; Renata Pasqualini; Wadih Arap
Journal:  Cancer Res       Date:  2017-04-20       Impact factor: 12.701

3.  Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.

Authors:  Phuong T Le; Kathleen A Bishop; David E Maridas; Katherine J Motyl; Daniel J Brooks; Kenichi Nagano; Roland Baron; Mary L Bouxsein; Clifford J Rosen
Journal:  Bone       Date:  2017-08-15       Impact factor: 4.398

4.  LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma.

Authors:  Ruida Xu; Fan Feng; Xiaosheng Yu; Zude Liu; Lifeng Lao
Journal:  Cell Prolif       Date:  2018-08-28       Impact factor: 6.831

5.  EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation.

Authors:  Gao Guo; Ke Gong; Nicole Beckley; Yue Zhang; Xiaoyao Yang; Rati Chkheidze; Kimmo J Hatanpaa; Tomas Garzon-Muvdi; Prasad Koduru; Arifa Nayab; Jennifer Jenks; Adwait Amod Sathe; Yan Liu; Chao Xing; Shwu-Yuan Wu; Cheng-Ming Chiang; Bipasha Mukherjee; Sandeep Burma; Bryan Wohlfeld; Toral Patel; Bruce Mickey; Kalil Abdullah; Michael Youssef; Edward Pan; David E Gerber; Shulan Tian; Jann N Sarkaria; Samuel K McBrayer; Dawen Zhao; Amyn A Habib
Journal:  Nat Cell Biol       Date:  2022-08-01       Impact factor: 28.213

Review 6.  The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease.

Authors:  Ravichandran Ramasamy; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Expert Opin Ther Targets       Date:  2015-11-11       Impact factor: 6.902

Review 7.  Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.

Authors:  Hyeon Jin Kim; Mi Suk Jeong; Se Bok Jang
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

Review 8.  Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.

Authors:  Salvatore Bongarzone; Vilius Savickas; Federico Luzi; Antony D Gee
Journal:  J Med Chem       Date:  2017-05-19       Impact factor: 7.446

9.  Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function.

Authors:  Joel Jules; Dony Maiguel; Barry I Hudson
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

10.  Association of the variants and haplotypes in the DOCK7, PCSK9 and GALNT2 genes and the risk of hyperlipidaemia.

Authors:  Tao Guo; Rui-Xing Yin; Wei-Xiong Lin; Wei Wang; Feng Huang; Shang-Ling Pan
Journal:  J Cell Mol Med       Date:  2015-10-23       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.